Biotech Values

[DewDiligence]

I highly doubt this, at least in the near future. The FDA is by far the easiest agency to work with and the fastest for drug approvals. The EMEA is slower and the reimbursement situation in the EU makes getting profit slower. Other regions are even more difficult (e.g japan PMDA).

Thanks for chiming in. I’m inclined to agree with you and disagree with Steve Burrill.